Cardiovascular Dynamics
This article was originally published in The Gray Sheet
Executive Summary
Firm gains FDA clearance to market the Periflow angioplasty/infusion catheter for small vessel angioplasty and infusion of contrast media to "remote, difficult-to-reach locations." Limited shipments of the device, which employs CVD's multiple microporous membrane technology, are slated to begin in late 1994 following completion of clinicals in the U.S. and Europe